Surgical Science Q4 2024: Growth should ramp in 2025e, margins might lag - Redeye

Redeye updates its estimates following Surgical Science’s Q4 2024 report. While we judge top-line growth was solid, margins were rather soft. Surgical Science recently announced the closing of its Intelligent Ultrasound acquisition and that 100% of da Vinci 5 system will feature simulation with a subscription-based model. Further, the company won a larger Educational Products tender. We update our estimates and valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/1080596/surgical-science-q4-2024-growth-should-ramp-in-2025e-margins-might-lag?utm_source=finwire&utm_medium=RSS